Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

Sam Altman, CEO of OpenAI, has clarified that the company has not yet achieved Artificial General Intelligence (AGI), despite ...

ChatGPT 5 release date is expected in early 2025, bringing advanced features like better conversations and multimodal support ...

was $540 now $319 for your first year Make up your own mind. Build robust opinions on the FT's trusted journalism. Offer available until 27 February 2025.

The race to increase human life span through ... that’s set to enter an early-stage trial in Australia this year. Some of the investment will come from OpenAI CEO Sam Altman, who also provided ...

OpenAI CEO Sam Altman has claimed ... this shift will be a natural part of life for generations. "My kid is never gonna grow up being smarter than AI," Mr Altman remarked on the Re: Thinking ...

OpenAI has demoed the AI agent browsing the web just like a human would, with the ability to interact with websites and ...

Kevin Zhou's Sam Altman, published in November 2024, is a detailed portrait of the AI entrepreneur, from his early days as a ... ended up taking part. The biography offers contradictory views ...

He offered the example of early cancer detection and the potential ... Using AI to analyze a blood sample could diagnose life-threatening cancers, he said. After gene-sequencing a cancerous ...

Kevin Zhou’s Sam Altman, published in November 2024, is a detailed portrait of the AI entrepreneur, from his early days as a Stanford University dropout to the launch of his first start-up ...